Target intelligence / Profile preview

Nescient helix-loop-helix 2 (NHLH2)

Target
NHLH2
Molecular classification
Transcription factor, Basic helix-loop-helix protein, Class A bHLH protein
01

Overview

Nescient helix-loop-helix 2 (NHLH2) is a transcription factor of the basic helix-loop-helix (bHLH) family, specifically of class A, that participates in the regulation of gene expression by binding to E-box motifs. NHLH2 is crucial in the development and function of the central and peripheral nervous system, particularly in neuroendocrine regulation and reproductive behavior. It is highly expressed in neurons involved in the hypothalamic-pituitary-gonadal axis, affecting body weight control, energy expenditure, and mating behavior. It acts as a transcriptional activator of genes such as NDN, PCSK1/3, MC4R, and KISS1, and regulates various neuropeptides influencing adult body weight and fertility. NHLH2 expression is controlled by hormonal signals (notably leptin and possibly estrogen), and it undergoes various post-translational modifications that modulate its activity. Loss of NHLH2 function in mice causes adult-onset obesity and infertility, and genetic variants in humans have been implicated in similar phenotypes. NHLH2 is not a classical therapeutic target (such as a druggable receptor or enzyme); it is primarily of interest as a transcriptional regulator and candidate risk gene in certain syndromes and metabolic conditions. Note: There are no known drugs directly targeting NHLH2 as of current knowledge, and its roles are mainly in genetic and developmental regulation rather than as a conventional pharmacological target.

Other names
Helix-loop-helix protein 2BHLHA34HEN2KIAA0490NSCL-2NSCL2bHLHa34Class A basic helix-loop-helix protein 34HEN-2HH27
02

Biological functions

Regulation of transcriptionNeuronal developmentRegulation of energy expenditureRegulation of body massReproductive behaviorHypothalamic-pituitary-gonadal axis functionCell differentiationApoptotic processCell migration in hindbrain
03

Disease associations

Hypogonadotropic hypogonadismObesityPotential role in neuroendocrine disordersPossible contribution to Prader-Willi and Angelman syndrome pathways
04

Safety considerations

None specifically reportedLoss of function in mice leads to obesity and infertility
05

Biomarkers

Single nucleotide polymorphisms (SNPs) in NHLH2 may serve as biomarkers for obesity risk

Beyond the preview

Go deeper on Nescient helix-loop-helix 2 (NHLH2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nescient helix-loop-helix 2 (NHLH2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call